SLC29A1 and cholangiocarcinoma: CCA patients with high hENT1 expression had a median PFS of 24 weeks and a median OS of 52 weeks, whereas CCA patients with low hENT1 expression had a median PFS of 11 weeks and a median OS of 26 weeks [22].